Anaptysbio, Inc financial data

Symbol
ANAB on Nasdaq
Location
10770 Wateridge Circle, Suite 210, San Diego, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 4, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 869 % -16.1%
Return On Equity -1.1K % -282%
Return On Assets -21.2 % +43%
Operating Margin -16.9 % +93.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 27.7M shares -9.01%
Common Stock, Shares, Outstanding 27.6M shares -9.38%
Entity Public Float 488M USD +33.1%
Common Stock, Value, Issued 28K USD -6.67%
Weighted Average Number of Shares Outstanding, Basic 27.8M shares -3.67%
Weighted Average Number of Shares Outstanding, Diluted 29M shares +0.43%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 169M USD +196%
Research and Development Expense 31.4M USD -25.6%
General and Administrative Expense 45.1M USD +6.29%
Operating Income (Loss) -28.7M USD +80.5%
Nonoperating Income (Expense) -55.9M USD -206%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -84.6M USD
Income Tax Expense (Benefit) 77K USD
Net Income (Loss) Attributable to Parent -84.6M USD +48.9%
Earnings Per Share, Basic -2 USD/shares +55.4%
Earnings Per Share, Diluted -2 USD/shares +55.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 110M USD -42.7%
Assets, Current 331M USD -26.3%
Property, Plant and Equipment, Net 1.5M USD -13.2%
Operating Lease, Right-of-Use Asset 13M USD -12.4%
Other Assets, Noncurrent 256K USD 0%
Assets 353M USD -28.4%
Accounts Payable, Current 2.89M USD -19.5%
Employee-related Liabilities, Current 9.01M USD +13.9%
Accrued Liabilities, Current 33.2M USD -13.6%
Liabilities, Current 38.1M USD -13.2%
Operating Lease, Liability, Noncurrent 12.6M USD -14%
Accumulated Other Comprehensive Income (Loss), Net of Tax 47K USD -93.8%
Retained Earnings (Accumulated Deficit) -822M USD -11.5%
Stockholders' Equity Attributable to Parent -29.4M USD -135%
Liabilities and Equity 353M USD -28.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -10.7M USD +71.3%
Net Cash Provided by (Used in) Financing Activities -28.6M USD -110%
Net Cash Provided by (Used in) Investing Activities 14.8M USD -78.4%
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 27.6M shares -9.38%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -24.4M USD -238%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 110M USD -42.7%
Interest Paid, Excluding Capitalized Interest, Operating Activities 18.1M USD
Deferred Tax Assets, Valuation Allowance 187M USD +23.7%
Deferred Tax Assets, Gross 194M USD +22.7%
Operating Lease, Liability 14.6M USD -11.4%
Payments to Acquire Property, Plant, and Equipment 35K USD +29.6%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -85.3M USD +47.5%
Lessee, Operating Lease, Liability, to be Paid 16.5M USD -13.2%
Property, Plant and Equipment, Gross 8.51M USD +3.79%
Operating Lease, Liability, Current 2.04M USD +8.11%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.69M USD +2.99%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.61M USD +3%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.88M USD -24.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.77M USD +3.02%
Deferred Tax Assets, Operating Loss Carryforwards 70.7M USD -2.82%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 6.91M USD +37.8%
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.85M USD +3%
Operating Lease, Payments 620K USD +2.99%
Additional Paid in Capital 793M USD -3.46%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 146K USD -10.4%
Share-based Payment Arrangement, Expense 35.8M USD +5.22%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%